MedPath

ACYCLOVIR

Approved
Approval ID

3b80d222-4d88-4ddd-afbf-8f316e9463d5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 10, 2011

Manufacturers
FDA

Stat Rx USA

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ACYCLOVIR

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-003
Application NumberANDA074980
Product Classification
M
Marketing Category
C73584
G
Generic Name
ACYCLOVIR
Product Specifications
Route of AdministrationORAL
Effective DateOctober 1, 2009
FDA Product Classification

INGREDIENTS (3)

ACYCLOVIRActive
Quantity: 800 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

ACYCLOVIR

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-370
Application NumberANDA074980
Product Classification
M
Marketing Category
C73584
G
Generic Name
ACYCLOVIR
Product Specifications
Route of AdministrationORAL
Effective DateOctober 1, 2009
FDA Product Classification

INGREDIENTS (4)

ACYCLOVIRActive
Quantity: 400 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACYCLOVIR - FDA Drug Approval Details